The bottom line: Non-traditional therapies provide vital options for the millions grappling with treatment-resistant depression, delivering faster relief and fewer side effects than conventional antidepressants for many patients. Innovations like ketamine infusions, esketamine nasal sprays, and transcranial magnetic stimulation target brain mechanisms directly, improving mood regulation and synaptic health, while psychedelic-assisted approaches and nutritional strategies offer complementary paths to enhanced well-being. Healthcare providers should prioritise personalised evaluations to integrate these evidence-based treatments, potentially transforming public mental health policies by expanding access and reducing reliance on long-term medication.

Depression is one of the most prevalent mental health conditions in the world, affecting an estimated 280 million people globally, according to the World Health Organization (WHO). While traditional treatments such as selective serotonin reuptake inhibitors (SSRIs), psychotherapy, and cognitive behavioural therapy (CBT) have been helpful for many, a significant portion of patients continue to struggle with treatment-resistant depression (TRD): a condition where symptoms persist despite trying two or more antidepressant medications.

Fortunately, recent years have witnessed a wave of mental health innovations, particularly in the realm of non-traditional therapies. These new approaches offer hope to individuals who haven’t responded well to conventional treatments. In this article, we’ll explore the leading non-traditional depression therapies reshaping mental health care today.

Ketamine-assisted therapy

One of the most well-researched and promising innovations in depression treatment is ketamine therapy. Originally used as an anaesthetic, ketamine has demonstrated rapid antidepressant effects, particularly in individuals with suicidal thoughts or severe depression.

How it works

Unlike SSRIs, which primarily target serotonin, ketamine interacts with NMDA receptors in the brain and influences glutamate, a neurotransmitter involved in mood regulation, memory, and learning. This action helps repair and regenerate synaptic connections, offering near-immediate relief in many cases.

Administration

• Intravenous (IV) infusion
• Intramuscular (IM) injection
• Nasal spray (see Spravato below)

Benefits

• Rapid reduction in symptoms (often within hours)
• Effective for patients with suicidal ideation
• Generally well-tolerated in clinical settings

But ketamine is classified as a Schedule III controlled substance, and it must be administered in a supervised medical environment to avoid misuse and monitor potential side effects such as dissociation and elevated blood pressure.

Esketamine nasal spray (Spravato)

Approved by the FDA in 2019, Spravato is a branded form of Esketamine, a derivative of ketamine. It is designed for treatment-resistant depression and is administered as a nasal spray under medical supervision in a certified clinic.

Esketamine represents a unique advancement because it is the first antidepressant to work through the glutamate system, offering an entirely new mechanism compared to traditional serotonin-based treatments.

Spravato treatment

The Spravato treatment protocol requires patients to remain in the clinic for at least two hours post-dose, during which healthcare professionals monitor vital signs and side effects. This ensures safety, as dissociation or changes in blood pressure can occur. Many patients begin to notice improvements within hours to days, unlike traditional antidepressants, which can take weeks to become effective.

Insurance and access

Some providers, like Kadelyx Health in Phoenix, Arizona, offer Spravato to qualified patients, especially those with BlueCross BlueShield of Arizona coverage, making it an accessible and promising option for those in need of faster, effective solutions.

Transcranial magnetic stimulation (TMS)

TMS is a non-invasive, FDA-approved treatment for major depressive disorder. It involves placing a magnetic coil near the scalp to deliver repetitive magnetic pulses that stimulate nerve cells in the prefrontal cortex: the brain region involved in mood regulation.

Key points

• Each session lasts 20–40 minutes
• No anaesthesia required
• Usually involves 5 sessions a week over 4–6 weeks

TMS is particularly useful for patients who haven’t responded to medications but prefer to avoid systemic treatments or drugs. Side effects are generally mild, such as headaches or scalp discomfort. In community-based clinical settings, TMS protocols are delivered under psychiatric supervision with individualised treatment parameters based on symptom profile and treatment history. Patients exploring TMS treatment in Santa Ana often undergo a comprehensive psychiatric evaluation prior to beginning therapy to determine suitability and optimise stimulation targeting. As research continues to refine neuromodulation approaches, TMS remains an important option within a broader, evidence-based depression treatment plan.

Psychedelic-assisted therapy

Psychedelic research is no longer limited to the fringes of science. Studies on psilocybin (magic mushrooms), MDMA (commonly known as ecstasy), and ayahuasca have revealed exciting possibilities in mental health therapy, especially for depression and PTSD.

Psilocybin for depression

A 2021 study published in The New England Journal of Medicine compared psilocybin to SSRIs and found it to be at least as effective, with fewer reported side effects. Participants reported increased emotional openness, reduced anxiety, and long-term mood improvement.

How it works

These substances help “reset” brain connectivity and enhance introspection and emotional processing, especially when combined with guided psychotherapy.

Challenges

Despite their promise, psychedelic therapies remain largely experimental and are only offered in clinical trials or research settings due to legal and regulatory restrictions.

Vagus nerve stimulation (VNS)

Vagus nerve stimulation is a more invasive method that involves implanting a device under the skin to send mild electrical pulses to the vagus nerve: a crucial communication pathway between the brain and body.

Originally used for epilepsy, VNS has gained attention for its ability to alleviate chronic depression in patients unresponsive to other treatments. However, it’s usually considered a last-resort option due to its surgical nature and cost.

Digital mental health tools and teletherapy

While not as dramatic as psychedelic or ketamine therapies, technology-based mental health tools are changing how people access care.

Examples

• AI-based chat therapy apps (e.g., Woebot)
• Telepsychiatry platforms
• Mood tracking apps
• Online CBT programmes

These tools make care more accessible, particularly for people in remote areas or with limited mobility. They also reduce the stigma by allowing individuals to seek help privately and on their own terms.

Nutritional psychiatry and gut-brain connection

Emerging research emphasises the link between gut health and mental well-being. Known as the gut-brain axis, this connection highlights how dietary changes and probiotic supplementation can influence neurotransmitter production and mood.

Key nutritional factors

• Omega-3 fatty acids
• Probiotics (Lactobacillus and Bifidobacterium)
• Vitamins B6, B12, and folate

While not a standalone treatment, nutritional strategies can complement non-traditional therapies and enhance overall recovery.

A new era in mental health care

Mental health care is undergoing a transformation. Non-traditional depression therapies (from Spravato treatment and TMS to psychedelic-assisted psychotherapy) offer real hope for those who haven’t found relief through conventional methods. These approaches not only expand treatment possibilities but also reflect a deeper understanding of the brain’s complexity.

It’s essential for individuals suffering from depression to consult with mental health professionals before exploring any new treatment. Personalized care, ongoing evaluation, and a combination of therapies often yield the best outcomes.

Robert Haynes, a psychology graduate from the University of Hertfordshire, has a keen interest in the fields of mental health, wellness, and lifestyle.